ArticleCancers2026

Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.

Patrick J Stiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.